The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 8, 2025 | Malin Life Sciences Holdings Ltd | 10% Owner | Tender(U) | 11.8M | — | — |
| Jan 8, 2025 | Yarema Kristin | President and CEO | Tender(U) | 616K | — | — |
| Jan 8, 2025 | Yarema Kristin | President and CEO | Disposed to issuer(D) | 345K | — | $0 |
| Jan 8, 2025 | Yarema Kristin | President and CEO | Disposed to issuer(D) | 498K | — | $0 |
| Jan 8, 2025 | Gergen Mark J | President and CEO, Director | Tender(U) | 637K | — | — |
| Jan 8, 2025 | Gergen Mark J | President and CEO, Director | Disposed to issuer(D) | 241K | — | $0 |
| Jan 8, 2025 | Gergen Mark J | President and CEO, Director | Disposed to issuer(D) | 173K | — | $0 |
| Jan 8, 2025 | Gergen Mark J | President and CEO, Director | Disposed to issuer(D) | 48K | — | $0 |
| Jan 8, 2025 | Gergen Mark J | President and CEO, Director | Disposed to issuer(D) | 519K | — | $0 |
| Jan 8, 2025 | Gergen Mark J | President and CEO, Director | Disposed to issuer(D) | 364K | — | $0 |
| Jan 8, 2025 | Gergen Mark J | President and CEO, Director | Disposed to issuer(D) | 75K | — | $0 |
| Jan 8, 2025 | Gergen Mark J | President and CEO, Director | Disposed to issuer(D) | 342K | — | $0 |
| Jan 8, 2025 | Leonhardt Harry J | GC & Chief Compliance Officer | Tender(U) | 224K | — | — |
| Jan 8, 2025 | Leonhardt Harry J | GC & Chief Compliance Officer | Disposed to issuer(D) | 160K | — | $0 |
| Jan 8, 2025 | Leonhardt Harry J | GC & Chief Compliance Officer | Disposed to issuer(D) | 137K | — | $0 |
| Jan 8, 2025 | Leonhardt Harry J | GC & Chief Compliance Officer | Disposed to issuer(D) | 73K | — | $0 |
| Jan 8, 2025 | Leonhardt Harry J | GC & Chief Compliance Officer | Disposed to issuer(D) | 125K | — | $0 |
| Jan 8, 2025 | Leonhardt Harry J | GC & Chief Compliance Officer | Disposed to issuer(D) | 112K | — | $0 |
| Jan 8, 2025 | Rizvi Syed Ali-aamir | Chief Medical Officer | Tender(U) | 185K | — | — |
| Jan 8, 2025 | Rizvi Syed Ali-aamir | Chief Medical Officer | Disposed to issuer(D) | 250K | — | $0 |
| Jan 8, 2025 | Mylet Johanna | Chief Financial Officer | Tender(U) | 255K | — | — |
| Jan 8, 2025 | Mylet Johanna | Chief Financial Officer | Disposed to issuer(D) | 65K | — | $0 |
| Jan 8, 2025 | Mylet Johanna | Chief Financial Officer | Disposed to issuer(D) | 73K | — | $0 |
| Jan 8, 2025 | Mylet Johanna | Chief Financial Officer | Disposed to issuer(D) | 125K | — | $0 |
| Jan 8, 2025 | Mylet Johanna | Chief Financial Officer | Disposed to issuer(D) | 112K | — | $0 |
| Jan 8, 2025 | Mylet Johanna | Chief Financial Officer | Disposed to issuer(D) | 82K | — | $0 |
| Jan 8, 2025 | Mylet Johanna | Chief Financial Officer | Disposed to issuer(D) | 80K | — | $0 |
| Jan 8, 2025 | Mylet Johanna | Chief Financial Officer | Disposed to issuer(D) | 4K | — | $0 |
| Jan 8, 2025 | Mylet Johanna | Chief Financial Officer | Disposed to issuer(D) | 35K | — | $0 |
| Jan 8, 2025 | Baum Charles M | Director | Tender(U) | 79K | — | — |
| Jan 8, 2025 | Baum Charles M | Director | Disposed to issuer(D) | 27K | — | $0 |
| Jan 8, 2025 | Baum Charles M | Director | Disposed to issuer(D) | 27K | — | $0 |
| Jan 8, 2025 | Baum Charles M | Director | Disposed to issuer(D) | 57K | — | $0 |
| Jan 8, 2025 | Collins Cynthia | Director | Tender(U) | 59K | — | — |
| Jan 8, 2025 | Collins Cynthia | Director | Disposed to issuer(D) | 27K | — | $0 |
| Jan 8, 2025 | Collins Cynthia | Director | Disposed to issuer(D) | 29K | — | $0 |
| Jan 8, 2025 | Collins Cynthia | Director | Disposed to issuer(D) | 87K | — | $0 |
| Jan 8, 2025 | Collins Cynthia | Director | Disposed to issuer(D) | 27K | — | $0 |
| Jan 8, 2025 | Lloyd Marcea Bland | Director | Tender(U) | 69K | — | — |
| Jan 8, 2025 | Lloyd Marcea Bland | Director | Disposed to issuer(D) | 27K | — | $0 |
| Jan 8, 2025 | Lloyd Marcea Bland | Director | Disposed to issuer(D) | 27K | — | $0 |
| Jan 8, 2025 | Lloyd Marcea Bland | Director | Disposed to issuer(D) | 29K | — | $0 |
| Jan 8, 2025 | Lloyd Marcea Bland | Director | Disposed to issuer(D) | 20K | — | $0 |
| Jan 8, 2025 | Lloyd Marcea Bland | Director | Disposed to issuer(D) | 20K | — | $0 |
| Jan 8, 2025 | Lloyd Marcea Bland | Director | Disposed to issuer(D) | 16K | — | $0 |
| Jan 8, 2025 | Lloyd Marcea Bland | Director | Disposed to issuer(D) | 32K | — | $0 |
| Jan 8, 2025 | Lloyd Marcea Bland | Director | Disposed to issuer(D) | 26K | — | $0 |
| Jan 8, 2025 | Schmid John P. | Director | Tender(U) | 59K | — | — |
| Jan 8, 2025 | Schmid John P. | Director | Disposed to issuer(D) | 29K | — | $0 |
| Jan 8, 2025 | Schmid John P. | Director | Disposed to issuer(D) | 32K | — | $0 |
| Jan 8, 2025 | Schmid John P. | Director | Disposed to issuer(D) | 26K | — | $0 |
| Jan 8, 2025 | Schmid John P. | Director | Disposed to issuer(D) | 20K | — | $0 |
| Jan 8, 2025 | Schmid John P. | Director | Disposed to issuer(D) | 20K | — | $0 |
| Jan 8, 2025 | Schmid John P. | Director | Disposed to issuer(D) | 16K | — | $0 |
| Jan 8, 2025 | Schmid John P. | Director | Disposed to issuer(D) | 27K | — | $0 |
| Jan 8, 2025 | Schmid John P. | Director | Disposed to issuer(D) | 27K | — | $0 |
| Jan 8, 2025 | Corning Luke | Director | Tender(U) | 59K | — | — |
| Jan 8, 2025 | Corning Luke | Director | Disposed to issuer(D) | 46K | — | $0 |
| Jan 8, 2025 | Corning Luke | Director | Disposed to issuer(D) | 27K | — | $0 |
| Jan 8, 2025 | Corning Luke | Director | Disposed to issuer(D) | 29K | — | $0 |
| Jan 8, 2025 | Corning Luke | Director | Disposed to issuer(D) | 27K | — | $0 |
| Jan 8, 2025 | Amado Rafael | Director | Tender(U) | 59K | — | — |
| Jan 8, 2025 | Amado Rafael | Director | Disposed to issuer(D) | 27K | — | $0 |
| Jan 8, 2025 | Amado Rafael | Director | Disposed to issuer(D) | 55K | — | $0 |
| Jan 2, 2025 | Gergen Mark J | Executive Chairman, Director | Tax withholding(F) | 23K | $9.60 | $224K |
| Dec 10, 2024 | Gergen Mark J | Executive Chairman, Director | Option exercise(M) | 30K | $2.78 | $83K |
| Dec 10, 2024 | Gergen Mark J | Executive Chairman, Director | Sell(S) | 30K | $9.46 | $284K |
| Dec 10, 2024 | Gergen Mark J | Executive Chairman, Director | Option exercise(M) | 30K | — | $0 |
| Nov 26, 2024 | Gergen Mark J | Executive Chairman, Director | Sell(S) | 30K | $9.27 | $278K |
| Nov 26, 2024 | Gergen Mark J | Executive Chairman, Director | Option exercise(M) | 30K | $2.78 | $83K |
| Nov 26, 2024 | Gergen Mark J | Executive Chairman, Director | Option exercise(M) | 30K | — | $0 |
| Jun 17, 2024 | Amado Rafael | Director | Grant(A) | 20K | — | $0 |
| Jun 17, 2024 | Amado Rafael | Director | Grant(A) | 27K | — | $0 |
| Jun 17, 2024 | Baum Charles M | Director | Grant(A) | 20K | — | $0 |
| Jun 17, 2024 | Baum Charles M | Director | Grant(A) | 27K | — | $0 |
| Jun 17, 2024 | Collins Cynthia | Director | Grant(A) | 20K | — | $0 |
| Jun 17, 2024 | Collins Cynthia | Director | Grant(A) | 27K | — | $0 |
| Jun 17, 2024 | Corning Luke | Director | Grant(A) | 20K | — | $0 |
| Jun 17, 2024 | Corning Luke | Director | Grant(A) | 27K | — | $0 |
| Jun 17, 2024 | Lloyd Marcea Bland | Director | Grant(A) | 20K | — | $0 |
| Jun 17, 2024 | Lloyd Marcea Bland | Director | Grant(A) | 27K | — | $0 |
| Jun 17, 2024 | Schmid John P. | Director | Grant(A) | 20K | — | $0 |
| Jun 17, 2024 | Schmid John P. | Director | Grant(A) | 27K | — | $0 |
| Apr 1, 2024 | Rizvi Syed Ali-aamir | Chief Medical Officer | Grant(A) | 185K | — | $0 |
| Apr 1, 2024 | Rizvi Syed Ali-aamir | Chief Medical Officer | Grant(A) | 250K | — | $0 |
| Mar 1, 2024 | Warner Brent | President, Gene Therapy | Tax withholding(F) | 36K | $4.13 | $148K |
| Mar 1, 2024 | Warner Brent | President, Gene Therapy | Grant(A) | 81K | — | $0 |
| Mar 1, 2024 | Warner Brent | President, Gene Therapy | Grant(A) | 112K | — | $0 |
| Mar 1, 2024 | Leonhardt Harry J | GC & Chief Compliance Officer | Grant(A) | 81K | — | $0 |
| Mar 1, 2024 | Leonhardt Harry J | GC & Chief Compliance Officer | Tax withholding(F) | 16K | $4.13 | $67K |
| Mar 1, 2024 | Leonhardt Harry J | GC & Chief Compliance Officer | Grant(A) | 112K | — | $0 |
| Mar 1, 2024 | Gergen Mark J | Executive Chairman, Director | Tax withholding(F) | 34K | $4.13 | $141K |
| Mar 1, 2024 | Mylet Johanna | Chief Financial Officer | Grant(A) | 81K | — | $0 |
| Mar 1, 2024 | Mylet Johanna | Chief Financial Officer | Tax withholding(F) | 18K | $4.13 | $75K |
| Mar 1, 2024 | Mylet Johanna | Chief Financial Officer | Grant(A) | 112K | — | $0 |
| Feb 1, 2024 | Gergen Mark J | Executive Chairman, Director | Tax withholding(F) | 47K | $3.41 | $161K |
| Jan 2, 2024 | Gergen Mark J | Executive Chairman, Director | Grant(A) | 125K | — | $0 |
| Jan 2, 2024 | Gergen Mark J | Executive Chairman, Director | Grant(A) | 173K | — | $0 |
| Jan 2, 2024 | Yarema Kristin | President and CEO, Director | Grant(A) | 250K | — | $0 |
| Jan 2, 2024 | Yarema Kristin | President and CEO, Director | Grant(A) | 345K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).